The FANCM:p.Arg658* truncating variant is associated with risk of triple-negative breast cancer
Gisella Figlioli, Jacopo Azzollini(Fondazione IRCCS Istituto Nazionale dei Tumori), Nirmala Pathmanathan(John Hunter Hospital), Desmond Yip(Calvary Hospital), Lesley Andrews(Prince of Wales Hospital), Banu Arun(The University of Texas Health Science Center at Houston), Nikolajs Zeps, Goska Leslie(University of Cambridge), Julian Adlard(Chapel Allerton Hospital), Adrienne Morey(John Radcliffe Hospital), Päivi Auvinen(University of Eastern Finland), Joe Dennis(University of Cambridge), Bernd Auber(Medizinische Hochschule Hannover), Christine B. Ambrosone(Unknown), Cora M. Aalfs(University of Amsterdam), Kyriaki Michailidou(Cyprus Institute of Neurology and Genetics), Deborah J. Marsh(University of Technology Sydney), Laura Caleca, Daniel R. Barnes(University of Cambridge), Bjarni A. Agnarsson(Reykjavík University), Sandra Viz-Lasheras(Centro de Investigación Biomédica en Red de Enfermedades Respiratorias), Nicholas Wilcken(Westmead Hospital), Norbert Arnold(Christian-Albrechts-Universität zu Kiel), Jane E. Dahlstrom(Australian National University), Ella Asseryanis(Comprehensive Cancer Center Vienna), Irene Catucci(IFOM), Stephen Braye(The University of Sydney), Muriel A. Adank(The Netherlands Cancer Institute), Massimo Bogliolo(Universitat Autònoma de Barcelona), Kristan J. Aronson(Queen's University), Taru Muranen(Karolinska Institutet), Johanna I. Kiiski(University of Helsinki), Roser Pujol(Universitat Autònoma de Barcelona), John Forbes(Breast Cancer Trials), Jane Carpenter(The University of Sydney), Allan Spigelman(The University of Sydney), Robert Baxter(The University of Sydney), Peter Simpson(The University of Queensland), Natalia Antonenkova(N.N. Alexandrov National Cancer Centre), Kristiina Aittomäki(University of Helsinki), Karen Cadoo(Memorial Sloan Kettering Cancer Center), Simona Agata(Istituto Oncologico Veneto), Hoda Anton-Culver(University of California, Irvine), Thomas Ahearn(University of Helsinki), Manjeet K. Bolla(University of Cambridge), Rodney Scott(The University of Queensland), C. Soon Lee(The University of Sydney), Volker Arndt(German Cancer Research Center)
Cited by 47
Related Papers
Intraepithelial CD8 <sup>+</sup> tumor-infiltrating lymphocytes and a high CD8 <sup>+</sup> /regulatory T cell ratio are associated with favorable prognosis in ovarian cancer
|Proceedings of the National Academy of Sciences|2005|2.4k
Association analysis identifies 65 new breast cancer risk loci
|Nature|2017|1.6k
2-year follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer: a randomised controlled trial
|The Lancet|2007|1.5k
Pembrolizumab versus paclitaxel for previously treated, advanced gastric or gastro-oesophageal junction cancer (KEYNOTE-061): a randomised, open-label, controlled, phase 3 trial
|The Lancet|2018|1.3k
Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes
|The American Journal of Human Genetics|2018|1.2k